Durability of and role of <scp>AKT</scp> in <scp>FGF7p</scp> urothelial protection against cyclophosphamide-Reference-Cited by-同舟云学术

Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide

Published:2022-06 Issue:12 Volume:10 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiological Reports

Author:

Narla Sridhar Tatarao¹^ORCID,Rice Lori²^ORCID,Ostrov David³,Bushnell Daniel Scott¹,Duara Joanne Lindsey⁴^ORCID,Bates Carlton Matthew¹⁵^ORCID

Affiliation:

1. Division of Nephrology Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

2. Department of Radiation Oncology College of Medicine University of Florida Gainesville Florida USA

3. Department of Pathology, Immunology, and Laboratory Medicine University of Florida College of Medicine Gainesville Florida USA

4. Division of Neonatology, Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

5. Division of Nephrology UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.15358

Reference31 articles.

1. A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

2. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

3. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells

4. KGF inhibits hypoxia-induced intestinal epithelial cell apoptosis by upregulating AKT/ERK pathway-dependent E-cadherin expression

5. Keratinocyte growth factor (KGF) regulates estrogen receptor‐alpha (ER‐alpha) expression and cell apoptosis via phosphatidylinositol 3‐kinase (PI3K)/Akt pathway in human breast cancer cells;Chang H. L.;Anticancer Research,2009